Trial Profile
Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis: a Randomized, Double-blind, Placebo-controlled Clinical Trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Jul 2018
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Cidofovir (Primary)
- Indications Recurrent respiratory papillomatosis
- Focus Therapeutic Use
- 24 Sep 2015 New trial record